Clinical trial
A Randomized Double Blinded Placebo-controlled Trial to Compare the Effect of Hyoscine-N-butyl Bromide (HBB) or Celecoxib Administered Alone Versus in Combination to Reduce Pain in Patients Undergoing Office Hysteroscopy.
NCT05911126 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double Blinded Placebo-controlled Trial to Compare the Effect of Hyoscine-N-butyl Bromide (HBB) or Celecoxib Administered Alone Versus in Combination to Reduce Pain in Patients Undergoing Office Hysteroscopy.
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 13, 2023
- Completion date
- December 13, 2023
- Enrollment
- 180 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.